Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New web app aims to give heart patients a voice in End-of-Life care

NCT ID NCT06090734

Knowledge-focused Sponsor: Duke-NUS Graduate Medical School Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a web-based platform called 'My Voice' that helps heart failure patients learn about their illness, decide on end-of-life care goals, and share those wishes with doctors and caregivers. About 244 patients in Singapore will use the tool to see if it increases advance care planning discussions. The goal is to make care planning easier and more patient-driven.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
My Voice web-based interactive platform
What this could lead to
If successful, this could provide a practical tool for heart failure patients to better communicate their end-of-life care wishes with doctors and family.
What could go wrong
This is an early-stage study with 244 participants, so results may not apply to all patients. The tool may not improve care discussions or reduce distress as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 244 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2024

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: \- The inclusion criteria for patients are 1. Age ≥ 21 years old 2. Singaporean or Permanent Resident 3. Diagnosed with heart failure 4. Symptoms classified under NYHA class II (with an ejection fraction of less than or equal to 35%), III or IV 5. Intact cognition determined through the Abbreviated Mental Test (AMT) (for pilot testing and main RCT) 6. Ability to speak and read English, Mandarin or Malay 7. Willing to complete a web intervention 8. Easily contactable via mobile phone or landline 9. Have a permanent address in Singapore for at least the next 1 year 10. Not recruited in a previous phase of the study The inclusion criteria for caregivers are 1. Age ≥ 21 years old 2. Nominated as a healthcare spokesperson by the patient or the main decision maker for the patient (for intervention arm only) 3. Ability to speak and read English, Mandarin or Malay 4. Willing to complete a web intervention 5. Easily contactable via mobile phone or landline 6. Have a permanent address in Singapore for at least the next 1 year Exclusion criteria for caregivers are: a) domestic helper

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Advance care planning are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Advance care planning Heart failure

Contacts and locations

Locations

  • Duke-NUS

    Singapore, Singapore, 169857, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.